Daxor Corporation (DXR)
DXR trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | DXR on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000027367 |
| Incorporated in | NY |
Financials
No annual revenue filed since the period ending 2011-12-31.
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No recent periodic report | None on EDGAR |
| Cash and burn | $60K cash; operating cash flow -$1.2M a quarter. | Report 2011-12-31 |
| Shares outstanding | No cover-page share count in XBRL | None on EDGAR |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Bush & Associates CPA LLC, Las Vegas, Nevada, United States | PCAOB Form AP 2026-03-05 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $19K, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q4 2011 2011-12-31 | $370K | -$1.5M | -$990K | $60K | No debt tags | $1.4M | 10-K 2012-03-28 |
| Q3 2011 2011-09-30 | $341K | -$4.2M | -$613K | $30K | No debt tags | Needs four quarters | 10-Q 2011-11-14 |
| Q2 2011 2011-06-30 | $358K | -$185K | Not filed | $112K | No debt tags | Needs four quarters | 10-Q/A 2011-08-31 |
| Q4 2010 2010-12-31 | $361K | $2.3M | -$1.8M | $58K | No debt tags | $1.6M | 10-K 2012-03-28 |
| Q3 2010 2010-09-30 | $453K | $2.6M | -$1.2M | $107K | No debt tags | Needs four quarters | 10-Q 2011-11-14 |
| Q2 2010 2010-06-30 | $368K | $188K | Not filed | $213K | No debt tags | Needs four quarters | 10-Q/A 2011-08-31 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B4 | 2026-01-26 |
| Latest annual report FORM 10-K | 10-K | 2012-03-28 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2011-11-14 |
| Latest current report | 8-K | 2026-06-24 |
| Latest proxy | DEF 14A | 2026-06-03 |
Source: SEC EDGAR submissions feed, 738 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +0.4% |
| 1 month | -18.1% |
| 3 months | -18.5% |
| Year to date | -42.5% |
| 1 year | -32.3% |
| From 52-week high | -42.5% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ADGM | Adagio Medical Holdings Inc | $1.61 | -16.58% | $44.2M |
| MBOT | Microbot Medical Inc. | $0.6444 | -34.16% | $43.3M |
| MDAI | Spectral AI Inc. | $1.31 | +0.77% | $42.2M |
| SRTS | Sensus Healthcare Inc. | $2.34 | +0.65% | $38.5M |
| QTEX | QTREX Quantum Ltd. | $1.15 | -8.00% | $64.4M |
| LNSR | LENSAR Inc. | $5.29 | +5.80% | $65.0M |
| TELA | TELA Bio Inc. | $0.7616 | -7.13% | $34.4M |
| NEPH | Nephros Inc. | $3.00 | -1.64% | $32.6M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier